To improve tractability, we investigate the linear programming-based approach to approximate dynamic programming. This approach can provide both feasible control policies and bounds on the MDPs' ...

AIRNA’s lead RNA editing product candidate, AIR-001, was further optimized for potency and durability, and AIRNA expects to file a clinical trial application in 2H 2025.